Molecular mechanism of U1 snRNP-mediated suppression of 3 prime end processing
Molecular mechanism of U1 snRNP-mediated suppression of 3 prime end processing
批准号:
244876233
负责人:
Privatdozent Dr. Jens Bohne
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The regulation of gene expression is the key to understand the wealth of sequence information available today. RNA is the central molecule in this process. The past years illustrated that both alternative mRNA processing and non-coding RNAs contribute substantially to the genomic complexity. Recently, it has been recognized that alternative usage of polyadenylation signals (PAS) is even more frequent than alternative splicing. Thus, the heterogeneity of mRNA 37nds is important for gene regulation. First, selection of different terminal exons leads to variations in the C-termini of proteins and second, differential length of 3/ untranslated regions (UTRs) determines seed regions for miRNAs or other RNA motifs regulating RNA stability or localization. So, alternative polyadenylation (APA) must be tightly controlled. Interestingly, U1 snRNP was shown to protect mRNAs from premature cleavage and polyadenylation (PCPA) and to contribute to variations in 3/UTR length besides its role in splicing.In parallel to the discovery of the new surveillance mechanism associated with U1 snRNP, we revealed the molecular pathomechanism of a previously unclassified 3/UTR mutation leading to a new complex immunodeficiency syndrome. A point mutation in the 3/UTR of the gene encoding p14/robld3 creates a 5/ splice site (SS), which is recognized by U1 snRNP and leads to a failure of 3/ end processing in the absence of splicing. Thus, suppression of intronic polyadenylation by U1 snRNP is important for the cell, but deleterious for p14 expression. It was previously assumed that the U1-70k subunit of U1 snRNP directly inhibits poly A polymerase. We could show that this is an unlikely scenario of PCPA suppression. We have preliminary data that U1 snRNP already inhibits cleavage of pre-mRNAs by targeting a factor of the 3/ end processing complex or by modulating the properties of RNA polymerase II. To address the molecular mechanism of PCPA suppression, we constructed two elegant reporter systems. One is a so-called tandem reporter characterized by a duplication of the p14 3/UTR. In addition, we have experience with a bi-directional Tet construct. A symmetric doxycycline inducible promoter drives expression of gene used for normalization and a p14 expression cassette simultaneously. This construct can be targeted to a pre-selected genomic locus by recombination. Many experimental questions like the identification of the RNA decay pathway or the component of U1 executing the suppression can be answered. Based on our data from histone reporter genes, we propose that U1 snRNP inhibits recognition of the PAS consensus sequence or targets a factor involved in cleavage of the pre-mRNA.The molecular analysis of this additional U1 snRNP function will have important implications for our understanding of a surveillance mechanism, which protects mRNAs genome-wide from premature transcriptional termination, but also allows for the accumulation of different mRNA isoforms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Herpesviral mRNP formation: identification of cellular co-factors and target specificity
-
批准号:403670311
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Privatdozent Dr. Jens Bohne
-
依托单位:
The role of 5' splice sites on nuclear mechanisms of regulated gene expression in retroviruses and cellular genes
-
批准号:41407192
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Privatdozent Dr. Jens Bohne
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: